# Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

> **NCT04917744** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 5 (actual)

## Conditions studied

- Ovarian Carcinoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Medical Chart Review

## Key facts

- **NCT ID:** NCT04917744
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2023-04-17
- **Final completion:** 2024-02-17
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04917744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04917744, "Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04917744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*